Trial Profile
Rosiglitazone and exercise in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2010
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 24 Oct 2006 New trial record.